Effective antitumor immunity depends on the coordinated activation of tumor antigen (Ag)-specific CD8+ cytotoxic T lymphocytes (CTLs) and CD4+ helper T cells, which recognize antigens presented by HLA class I and II proteins, respectively [10,11,12,13]. The gene discussed is CD4; the disease is neoplasm.